Rothschild & Co Asset Management US’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-77,587
| Closed | -$10.5M | – | 589 |
|
2017
Q1 | $10.5M | Buy |
77,587
+2,917
| +4% | +$395K | 0.12% | 238 |
|
2016
Q4 | $10.7M | Sell |
74,670
-18,209
| -20% | -$2.61M | 0.14% | 226 |
|
2016
Q3 | $11M | Buy |
92,879
+7,292
| +9% | +$861K | 0.19% | 202 |
|
2016
Q2 | $9.07M | Buy |
85,587
+14,058
| +20% | +$1.49M | 0.16% | 215 |
|
2016
Q1 | $7.97M | Sell |
71,529
-7,382
| -9% | -$823K | 0.15% | 211 |
|
2015
Q4 | $12.4M | Sell |
78,911
-54,071
| -41% | -$8.47M | 0.23% | 148 |
|
2015
Q3 | $17.5M | Sell |
132,982
-204
| -0.2% | -$26.8K | 0.34% | 96 |
|
2015
Q2 | $23.2M | Sell |
133,186
-40,074
| -23% | -$6.97M | 0.43% | 65 |
|
2015
Q1 | $29.9M | Sell |
173,260
-26,804
| -13% | -$4.62M | 0.57% | 46 |
|
2014
Q4 | $26M | Buy |
200,064
+111,108
| +125% | +$14.5M | 0.52% | 54 |
|
2014
Q3 | $11.4M | Sell |
88,956
-3,820
| -4% | -$491K | 0.24% | 124 |
|
2014
Q2 | $8.21M | Sell |
92,776
-429
| -0.5% | -$38K | 0.17% | 205 |
|
2014
Q1 | $8.76M | Buy |
93,205
+22,937
| +33% | +$2.16M | 0.2% | 188 |
|
2013
Q4 | $7.95M | Buy |
70,268
+1,593
| +2% | +$180K | 0.18% | 209 |
|
2013
Q3 | $5.42M | Buy |
68,675
+2,700
| +4% | +$213K | 0.12% | 258 |
|
2013
Q2 | $4.34M | Buy |
+65,975
| New | +$4.34M | 0.1% | 277 |
|